Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856459) titled 'ABVN Phase 2 - EDS Wearable Device' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Indiana University

Condition: Ehlers-Danlos Syndrome Healthy Subjects

Intervention: Device: ML1101 Stimulus Isolator

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: July 30, 2024

Target Sample Size: 58

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07856459

Published by HT Digital Content Services with per...